Critical Healthcare Resources
To ensure continued access to important information critical to members and their patients, ACOG is reposting content currently at a risk of becoming unavailable. These Federal resources are important for members, women’s health care professionals, patients, and the public.
The following documents are developed by various Federal agencies and are listed for educational purposes only. These documents should not be considered ACOG guidance.
Abortion
-
Abortion Surveillance – United States, 2022 (CDC) | Download PDF
This resource collates and presents epidemiologic data on abortion care from across the U.S. It can be used to understand changing trends in abortion provision and in patients accessing abortion care.
Contraception
-
Providing Quality Family Planning Services (HHS) | Download PDF
Focuses on provision of equitable, person-centered sexual and reproductive health services
Providing Quality Family Planning Services, Overview (HHS) | Download PDF
A summary of how the updated 2024 recommendations differ from the last iteration in 2014.
Health Equity
-
Advancing Health Equity for Intersex Individuals (HHS) | Download PDF
This report from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, provides equity recommendations. It aims to increase awareness among health care providers, patients, and families about the harms of some current medical practices for intersex patients and share promising practices for advancing health equity for intersex people.
Breast Cancer: Black Women Have Higher Death Rates from Breast Cancer Than Other Women (Vital Signs, CDC) | Download PDF
This resource discusses higher death rates of breast cancer in black women.
Infectious Disease
-
GRADE Evidence Tables for Vaccines (CDC) | Download PDF
This GRADE (Grading of Recommendations, Assessment, Development and Evaluation) resource provides Morbidity and Mortality Weekly Report (MMWR) published evidence.
Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States (NIH) | Download PDF
Recommendations regarding HIV screening in pregnancy, the treatment of pregnant people with HIV, and the use of antiretroviral (ARV) drugs to prevent perinatal (vertical) HIV transmission (i.e., during pregnancy and labor and delivery) and postnatal HIV transmission (i.e., through breastfeeding).
Maternal Morbidity and Mortality
-
Pregnancy Mortality Surveillance System (CDC) | Download PDF
This data set provides national data that can track both proportionate mortality and pregnancy-related mortality ratios over time. The Pregnancy Mortality Surveillance System (PMSS) has national participation, consistent information available, and consistent coding rules applied over long time periods and across jurisdictions. PMSS can tell the story of disparities.
Pregnancy-Related Deaths: Data From Maternal Mortality Review Committees in 38 U.S. States, 2020 (CDC) | Download PDF
Maternal Mortality Review Committees (MMRCs) are multidisciplinary groups and teams that convene at the state or local level to comprehensively review deaths during or within one year of the end of pregnancy (pregnancy-associated deaths). Data on 525 pregnancy-related deaths among women residing in 38 states during 2020 were shared with the Centers for Disease Control and Prevention (CDC) through MMRIA.
Because of access to broad data sources and expertise, MMRCs can increase our understanding of the medical and non-medical contributors to deaths, and specific prevention opportunities.
Sexual Health
-
2025 National Youth Risk Behavior Survey–National High School Questionnaire (CDC) | Download PDF
This questionnaire was developed for the Spring 2025 Youth Risk Behavior Surveillance System. It includes a question about transgender identity.
Overview and Methods for the Youth Risk Behavior Surveillance System (CDC) | Download PDF
This report from 2023 is the first year that a transgender identity question was included in the standard and national Youth Risk Behavior Surveillance System (YRBSS) questionnaire.
Substance Use Disorder
-
Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons — 24 U.S. Jurisdictions, 2017 and 2019 (CDC) | Download PDF
In 2017 and 2019, during their most recent health care visit, 80% of pregnant persons reported being asked about their alcohol use; only 16% of those with past 30-day alcohol consumption were advised by a health care provider to quit or reduce their alcohol use.
Explore ACOG Endorsed Documents
Access our list of documents that have ACOG's endorsement and are considered official ACOG clinical guidance.
GoDisclaimer
Materials on this page are hosted to ensure our members can access the documents when needed. Documents appearing on this page are government-created resources and were not written or authored by ACOG.
The American College of Obstetricians and Gynecologists (ACOG) reviews its publications regularly; however, its publications may not reflect the most recent evidence. A reaffirmation date is included in the online version of a document to indicate when it was last reviewed. The current status and any updates of this document can be found on ACOG Clinical at acog.org/lot.
This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology.
While ACOG makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.